Related Experiment Video
Updated: Jun 7, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Hypertension and cardiovascular risk: the J-curve concept]
A Yannoutsos1, J-J Mourad, Jacques Blacher
1Unité Hypertension Artérielle, Prévention et Thérapeutique Cardiovasc., Centre de Diagnostic et de Thérapeutique, Hôtel-Dieu, Université Paris.
Insights
Optimizing pharmacologic treatment for hypertension is crucial due to high prevalence and poor blood pressure control. Lowering blood pressure reduces cardiovascular risk, but overly strict goals may be detrimental.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension is prevalent, especially in the elderly, with over half of patients lacking adequate blood pressure control.
- Associated cardiovascular risk factors and residual risk under treatment necessitate optimized pharmacologic strategies.
- Interventional studies demonstrate a cardiovascular risk reduction proportional to blood pressure lowering.
Purpose of the Study:
- To evaluate the optimal blood pressure targets in hypertensive patients.
- To address the controversies surrounding strict blood pressure goals and the J-Curve phenomenon.
Main Methods:
- Review of interventional studies and clinical trials on hypertension management.
- Analysis of guidelines for blood pressure targets in different patient populations.
- Examination of the J-Curve concept regarding cardiovascular morbidity and mortality.
Main Results:
- Current guidelines suggest targets below 140/90 mmHg for essential hypertension and below 130/80 mmHg for secondary prevention (e.g., diabetes, renal impairment).
- Clinical trials do not consistently confirm the benefit of strict blood pressure goals in high-risk patients; potentially deleterious effects observed.
- The "lower the better" concept is being reconsidered due to the J-Curve hypothesis.
Conclusions:
- The optimal blood pressure target in hypertension requires careful consideration, balancing benefits of reduction against potential risks of overly strict goals.
- The J-Curve phenomenon, suggesting increased risk with very low blood pressure, remains an area of ongoing research and debate.
- Individualized treatment strategies are essential for managing hypertension and its associated cardiovascular risks.
Abstract:
The optimization of the pharmacologic treatment in hypertensive patients is encouraged by four reports: the high prevalence of hypertension and more particularly in the elderly, the lack of blood pressure control in more than half of patients, the frequency of the association to other cardiovascular risk factors and the existence of a residual risk under treatment. All these factors are combined to raise the cardiovascular risk in hypertensive patients. Several interventional studies highlighted a reduction of the cardiovascular risk proportional to the reduction of blood pressure under treatment. Thus arose the question of the optimal blood pressure: the guidelines propose values lower than 140/90 mmHg for the non-complicated essential hypertension and lower than 130/80 mmHg in secondary prevention, for the patients with diabetes or renal impairment. However, this strict blood pressure goal for the high cardiovascular risk patients is not confirmed by clinical trials, strict blood pressure goal being potentially deleterious. The concept of «the lower the better» tends to be abandoned. Since more than three decades, the assumption of a paradoxical increase of the cardiovascular morbidity and mortality associated with a high reduction of blood pressure (the «J-Curve» concept) remains the subject of many studies and controversies.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
